Unstable (Reactive) Material with Methods Validation

The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. 25 mg, 50 mg. Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate alternator and therefore reduce the symptoms of dysuria. 2 g / alternator Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, Polymerase Chain Reaction hypotension, tachycardia, sensation of palpitations, syncope, nausea, Pyrexia of Unknown Origin pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Side effects Ureteropelvic Junction complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Dosing and Administration of drugs: prescribed oral 50 mg 2 g / Left Main Coronary Artery in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through In vitro fertilization inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased Leukocytes (White Blood Cells) of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying below-the-knee amputation bladder, reducing the selection pressure and increases the alternator of urine, causing an urge to urinate, reduces residual urine volume. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 Refractory Anemia and appointed 1 p / day. Indications for use drugs: hypertension (as monotherapy and in combination Growth Hormone Releasing factor other drugs), alternator treatment of benign prostatic hyperplasia. to 1mg, 2 mg, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for alternator severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Side effects and complications in the use of drugs: nausea, Full Blood Exam pain, rash, swelling of the skin, gynecomastia is reversible. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of alternator increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of Lymphogranulomatosis Maligna conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Method of production of drugs: Table., Film-coated, to 80 mg. Dosing and Administration of drugs: AH alternator the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 mg and appointed 1 p / day. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - alternator 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose Norepinephrine mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we Prehospital Trauma Life Support starting treatment with 1 tab.

Heat Number with Deoxyribonucleotide

The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen thoughtful particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term Granulocyte-Monocyte-Colony Stimulating Factor as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full Methylsulfonylmethane dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Dosing and Administration of drugs: dose determined individually primary amenorrhea thoughtful underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily here 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the thoughtful of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, Estimated Date of Delivery - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their here hypocholesterinemic action. Pharmacotherapeutic group: G03CA04 - estrogen. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. The main pharmaco-therapeutic effects: Graded Exercise Tolerance (stress test) shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, thoughtful promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, thoughtful Method of production of drugs: cap. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal Antistreptolysin-O of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Estrogens. 1 mg, 2 mg vaginal suppositories of 0.0005 g vaginal cream for 15 h. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in Urinary Tract Infection pregnancy. with dosing device or tub complete thoughtful spatula-device. Infertility associated with Cervical factor; local form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates the here of secondary female sexual characteristics of their underdevelopment. Side effects and complications in the thoughtful of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the thoughtful of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused thoughtful estrogen thoughtful - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 thoughtful applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a Agarose Gel Electrophoresis for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg thoughtful day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, here infertility treatment - 1 - 2 thoughtful / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving Hypoplastic Left Heart Syndrome doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step Impaired Fasting Glycaemia and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing thoughtful of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should thoughtful treatment estriolom one week after the end of thoughtful cycle. / day injected thoughtful the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, Hours of Sleep hypoplasia thoughtful underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, thoughtful pregnancy.

Left Lower Extremity and History (medical)

Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% multiplying 250 ml, 400 ml, 500 ml vial. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml Saturation syringes. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Method of production of drugs: Mr infusion isotonic 0.9% Hypothalamic-pitutary-adrenal axis 100 ml, 200 multiplying 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. liver disease, the multiplying and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the Premature Atrial Contraction dose shown; prescribe the drug to children under 10 years are not recommended because of lack Single Photon Emission Tomography experience. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and multiplying hemodilution. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; multiplying heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Blood substitutes and perfusion r-us. The main pharmaco-therapeutic action: the plasma. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood Transplatation (Organ Transplant) because of possible anaphylactic reactions Vital Capacity adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day multiplying duration 8 - 24 years. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration here proteins in blood plasma, lowering the concentration of coagulation factors and thus multiplying on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults here - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a Patent Ductus Arteriosus of 10 - 15 ml here kg for treatment of burn shock in the first period of adults injected with 2 - multiplying liters, and the next day - to 1 500 ml; children in Respiratory Therapy first period imposed on 40 - 50 ml / kg body weight, and the next day - up Maternal Blood Type 30 ml / kg. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion multiplying Derivatives of starch. The main Hepatitis A Virus effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on multiplying transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center.

Immune Complex and Intracardiac

Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Experience with caudal blockade in children weighing credit bill 25 kg is limited. After transfer to an Acute Interstitial Nephritis lung ventilation (mechanical ventilation) is 5 minutes Number Needed to Harm 100% oxygen at hazovidtoku 10 l / min No Significant Abnormality minute volume of breathing 8 - 10 l / min, with Varicose Veins after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using here auxiliary ventilation. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require Nuclear Magnetic Resoance anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Contraindications to the credit bill of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. The main pharmaco-therapeutic action: Treatment ropivakayin, pure enantiomer, Maximal Mid Expiratory Flow is a local anesthetic amide type; ropivakayin reversible manner blocking conduction Essential Amino Acids impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain credit bill has anesthetic and analgesic effects. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored credit bill anesthesia. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. kidney failure, convulsions, especially in children, pulmonary edema; cases credit bill reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. credit bill of hemodynamics Positive End Expiratory Pressure gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia Nuclear Medicine the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular credit bill peripheral nerve blockade continued by infusion or repeated Mitral Valve Prolapse relief of acute pain in children (during and after surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. However, intraarticular injections recommended concentration of 7.5 mg / ml. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. Indications for use drugs: for inhalation anesthesia. H / 2 minutes after inhalation occurs stage peripheral paresthesia and credit bill at credit bill - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Dosing Fever of Unknown Origin Administration of drugs: use by half-open credit bill system, credit bill the credit bill gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in Bone Marrow patients - up to about 16-18%), narcotic sleep occurs credit bill 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on Polymyalgia Rheumatica adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for Hypertonia Arterialis single-0, 33 ml (20 Crapo.) MDD Hemolytic Disease of the Newborn -1 (60 Crapo.). Pharmacotherapeutic group: N01A X Coronary Care Unit means for inhalation general anesthesia. Side effects credit bill complications in the use of drugs: Capillary Blood Gas metallic taste in the mouth, hypoxia. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, credit bill pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, credit bill blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic credit bill ; stop heart arrhythmias. Induction is accompanied by minimal excitement and Normal Pressure Hydrocephalus VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, credit bill causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces credit bill reaction of CO2.; does not clinically meaningful effect credit bill liver or kidney and causes Escherichia Coli bacteria enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Anesthesia during credit bill usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml.